Immunome, Inc. (IMNM) announced on July 1, 2025, that its Compensation Committee granted inducement awards. The awards include non-statutory stock options to purchase a total of 125,500 shares of common stock.
These options were granted to 8 new employees under the 2024 Inducement Plan. The stock options were approved as an inducement material to employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Each option has an exercise price of $8.47, matching the closing sales price on July 1, 2025. The options will vest over four years, with 25% vesting after one year.
The remaining shares will vest monthly over the next 36 months.
Vesting depends on the employees’ continued service through the vesting dates.
